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Cancer  is  the  second  cause  of  overall 
  mortality in the world (Abegunde et al., 
2007),  with  approximately  12.5  million 
new  cases  and  7.5  million  deaths  each 
year (Ferlay et al., 2010; Jemal et al., 2011). 
Many cancers are preventable, and cancer 
control represents a global challenge which 
will  be  significantly  aided  by  increasing 
our knowledge of distribution, causes, and 
methods  for  prevention  of  cancer.  This 
journal, Frontiers in Cancer Epidemiology 
and  Prevention,  is  dedicated  to  publish-
ing  papers  on  the  distribution,  etiology, 
and prevention of cancer. In this article, 
we present our vision for the Journal. We 
discuss what has been discovered, what lies 
ahead, and what papers we hope to receive 
from  authors.  The  overall  scope  of  the 
Journal is summarized in Figure 1.
In the past few decades, cancer registries 
have produced data on incidence, preva-
lence, and mortality of cancers in many 
regions of the world, and shown variations 
by sex, race, geographic region, and other 
demographic  determinants.  Examples 
include  the  Surveillance  Epidemiology 
and End Results (SEER) program in the 
United States (Hayat et al., 2007) and the 
compilation of cancer registry data within 
the volumes of Cancer Incidence in Five 
Continents (Parkin et al., 2010). We now 
have a reasonably good idea of distribu-
tion of cancers in many areas of the world, 
overall and within specific subgroups of the 
population. This is a unique and fortunate 
characteristic of the descriptive epidemiol-
ogy of cancer, compared to other chronic 
diseases.  However,  cancer  incidence  and 
mortality rates change; hospitals and cancer 
registries prepare new reports; and new reg-
istries are established. We welcome reports 
on the incidence, prevalence, and mortality 
from cancers from all over the world and 
manuscripts based on original analyses of 
descriptive data.
Whereas by 1950 little was established 
about  etiology  of  cancer,  epidemiologic 
studies in the past 60 years have helped us 
know about some major causes of many 
cancers.  One  can  cite  many  examples. 
Groundbreaking  case–control  studies  by 
Doll and Hill (1950), Wynder and Graham 
(1950), and Levin et al. (1950) in the early 
1950s established smoking as a cause of can-
cer. In the past two decades, a large number 
of case–control, cohort, and nested case–
control  studies  showed  the  strong  asso-
ciation  between  certain  types  of  human 
papillomavirus (HPV) and cervical cancer, 
and later cancers of the vulva, vagina, penis, 
anus, oral cavity, and oropharynx and tonsil 
(Munoz et al., 2003; Bouvard et al., 2009). 
The causal role of hepatitis B virus (HBV) 
and hepatitis C virus (HCV) infection in 
hepatocellular carcinoma (Bouvard et al., 
2009) and of several occupational exposures 
in a variety of cancers (Baan et al., 2009) are 
other important examples. Likewise, since 
2006,  genome-wide  association  studies 
have shown over 100 associations between 
common genetic polymorphisms and risk 
of  various  cancers  (Stadler  et  al.,  2010). 
Notwithstanding  these  discoveries,  there 
remains much to be understood in rela-
tion to the etiology of cancer. Association 
of physical activity (Prentice et al., 2004; 
Reeves et al., 2007), shift-working (Straif 
et al., 2007; Stevens et al., 2011), and expo-
sure to many chemical agents and mixtures 
(Ritz and Rull, 2008; Olsson et al., 2011) 
with cancer are a few examples. Studying 
environmental risk factors of cancer, from 
childhood,  in  repeated  measures,  with 
considering potential modifying effect of 
other factors such as microbiome, and in 
the light of development and teratogenesis, 
may increase our understanding of cancer 
risk  factors  (Wild,  2005,  2011;  Hanash, 
2011; Perera, 2011; Potter, 2011; Rappaport, 
2011; Spitz, 2011). The continuing decline 
in cost of sequencing will make it possible to 
identify rare polymorphisms that strongly 
increase risk of cancer. The Journal wel-
comes reports on new factors associated 
with risk of cancer that may have a possible 
etiologic role, as well as null results from 
high-quality studies.
Epidemiologic  studies  can  use  new 
instruments or refine modeling to provide 
better understanding of the causes of can-
cer. For example, it has been suggested that, 
compared to food frequency questionnaires, 
using multiple 24-h recalls may increase our 
ability to measure diet more accurately and 
hence reduce measurement error (Schatzkin 
et al., 2009b). During the past few decades, 
a wide range of biomarkers has also been 
applied to cancer epidemiology (Boffetta, 
2010; Hartman et al., 2010). A classic exam-
ple of successful application of biomarkers 
in cancer epidemiology is the study between 
aflatoxins and risk of hepatocellular carci-
noma (Ross et al., 1992). However, intra-
individual variability (e.g., diurnal variation 
in hormonal level) and measurement error 
(e.g., sampling and laboratory variation) 
do also occur with biomarkers, and most 
biomarker studies rely on a single biologi-
cal sample, which may not represent long-
term  exposures.  Many  investigations  are 
being conducted to identify new biomar-
kers and improve the validity and preci-
sion of existing biomarkers. Cancer results 
from a complex interplay of environmental, 
genetic, and epigenetic factors (Spitz and 
Bondy, 2010). New modeling strategies have 
increased  our  ability  to  more  accurately 
study  well-established  associations  such 
as  the  association  between  smoking  and 
lung cancer (Lubin et al., 2008), as well as 
the association of diet (Ferrari et al., 2008; 
Schatzkin et al., 2009a) or genetic factors 
(Pashayan et al., 2011; Wakefield et al., 2010) 
with cancer, and to better control the effects 
of  confounding  factors  (de Vocht  et  al., Frontiers in Oncology  | Cancer Epidemiology and Prevention    April 2011  | Volume 1  | Article 3  |  2
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(Callinan et al., 2010) and are expected 
to reduce the burden of tobacco-related 
cancers  in  those  populations  (Alberg 
et al., 2007; Sturgis and Cinciripini, 2007). 
Discovery of HPV as a cause of cervical 
cancer has successfully led to the develop-
ment of effective vaccines against potent 
carcinogenic types of HPV (Monsonego 
et al., 2010). Global vaccination of new-
borns against HBV is another example of 
success that has reduced the rate of hepa-
tocellular  carcinoma  in  Taiwan  (Chang 
et al., 2009) and would likely lead to seri-
ous  declines  in  the  worldwide  rates  in 
the coming decades (Yang and Roberts, 
2010).  Rapid  reduction  of  the  cost  of 
genetic information has made it possible 
to screen and take actions when cancer risk 
(Brennan et al., 2004; Allen et al., 2009; 
Hashibe  et  al.,  2009;  Cook  et  al.,  2010; 
Gallicchio et al., 2010; Zheng et al., 2011). 
Requirements and considerations for suc-
cessful execution of large studies and mak-
ing fruitful collaborations between multiple 
groups  have  been  discussed  elsewhere 
(Boffetta et al., 2011). We invite papers from 
such consortia and large-scale studies.
Cancer prevention, using the knowl-
edge from epidemiology and molecular 
biology,  has  achieved  many  successes. 
Recognition  of  smoking  as  an  impor-
tant cause of lung cancer has resulted in 
smoking control policies in Europe, the 
United States, and some other countries 
(Chaloupka  et  al.,  2011)  that  have  in 
turn reduced exposure to tobacco smoke 
2009). The Journal accepts papers on new 
instruments or biomarkers, improved sta-
tistical models, and also stronger studies of 
previously known associations.
Study subjects in epidemiological stud-
ies generally have heterogeneous environ-
mental exposures and genetic background, 
which interact with each other and may 
influence the association between risk fac-
tors and health outcomes. In order to study 
such  interactions,  epidemiologic  studies 
require  large  sample  sizes,  and  therefore 
epidemiology  falls  into  the  category  of 
“big science” (Kreeger, 2003). Large cohort 
studies, pooling and consortia of several 
studies, networks, and “networks of net-
works”  have  been  helpful  in  achieving 
large sample sizes and to study   interactions 
Figure 1 | Cancer research areas that are within the scope of Frontiers in Cancer Epidemiology and Prevention*.
*Null results from high-quality studies are also welcome.
aIncluding environmental, genetic, and epigenetic factors and their interactions.
bIncluding advances in data collection methods and biomarkers, as well as translational studies.www.frontiersin.org  April 2011  | Volume 1  | Article 3  |  3
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predict  survival  much  more  accurately. 
Some  prognostic  factors  are  modifiable 
and active secondary prevention activities 
can be undertaken to prolong survival. For 
example, improving awareness of effective 
screening methods and enhancing health 
services to offer such screening could lead 
to  downstaging  of  cancers.  We  welcome 
reports on survival of cancer patients and 
its prognostic factors, and also research on 
methods  leading  clinical  downstaging  of 
cancers.
In addition to original research papers, 
we  encourage  authors  to  submit  review 
articles,  systematic  reviews,  and  meta-
analyses. These articles help establish or 
exclude associations (Kellen et al., 2007; 
Islami and Kamangar, 2008; Renehan et al., 
2008; Lee et al., 2009; Turati et al., 2010; 
Gandini et al., 2011), revise estimates of ini-
tially inflated associations that may happen 
due to publication bias (Kamangar et al., 
2006a), suggest associations or interactions 
relevant to cancer research (Minelli et al., 
2011), or identify gaps in a research field 
(Islami et al., 2009).
Whereas the Journal is mainly dedicated 
to human studies, we also invite papers on 
animal or laboratory studies that have a 
direct  relevance  to  cancer  prevention  in 
humans (Kern et al., 1991; Kim et al., 1991; 
Jokelainen et al., 1994; Watanabe et al., 1998; 
Wang et al., 2010). For example, papers that 
show high amounts of mutagenic or car-
cinogenic substances in certain foods and 
beverages (Zhang et al., 1983; Kamangar 
et al., 2008; Perello et al., 2008) will fall in 
the repertoire of this Journal.
In  summary,  while  we  have  learned 
much about the distribution, etiology, pri-
mary and secondary prevention of cancer 
in one century of systematic research, many 
things remain to be learned. Development 
of  large-scale  trials  and  cohort  studies, 
consortia of analytical epidemiology stud-
ies, new statistical methods, novel meas-
urement methods, ever-increasing ability 
to sequence genome, among other factors, 
are giving us the opportunity to delve more 
deeply into research questions. We believe 
that Frontiers in Cancer Epidemiology and 
Prevention will play an important role in 
disseminating new knowledge in this field 
and can increase communication among 
basic scientists, epidemiologists, clinicians, 
and public health professionals in the field 
of oncology.
is very high, such as in individuals with 
certain BRCA1 mutations (Balmana et al., 
2010). On the other hand, cancer preven-
tion science has also faced many failures. A 
number of initially promising agents were 
later shown to have either no effect or even 
cause harm. Well-known examples include 
the failure of alpha-tocopherol and beta-
carotene in preventing lung cancer (The 
Alpha-Tocopherol, Beta Carotene Cancer 
Prevention Study Group, 1994) and failure 
of selenium in preventing prostate cancer 
(Lippman et al., 2009). The Journal invites 
papers on new findings and methods on 
cancer prevention research. We are inter-
ested in receiving papers on both successes 
and  failures  of  agents  that  are  hypoth-
esized to prevent cancer, including che-
mopreventive agents, vaccines, or lifestyle 
modification.  We  especially  encourage 
submission of randomized clinical trials.
The  Journal  also  accepts  papers  on 
screening  and  secondary  prevention  of 
cancer. It has now been well established 
that early screening for cervical, colorec-
tal,  and  breast  cancers  through  various 
methods can save lives (Sankaranarayanan 
et al., 2009; Schiffman and Solomon, 2009; 
US Preventive Services Task Force, 2009; 
Cunningham et al., 2010). New screening 
methods are being continuously devised; 
criteria are revised by age and sex; and revi-
sions are made due to changes in effective-
ness of treatments and invasiveness and 
cost of procedures. Screening studies are 
subject  to  a  number  of  potential  biases 
(Croswell  et  al.,  2010),  and  new  studies 
often refine previous studies and correct 
for  biases.  Publications  of  high-quality 
screening studies are within the scope of 
this Journal.
With rising availability of early detection 
facilities and more efficient treatments, sur-
vival of cancer patients has increased over-
all (Jemal et al., 2010). Survival has been 
shown to be related to a number of factors, 
including  cancer  site  (e.g.,  breast  versus 
pancreatic cancer), stage, age, other demo-
graphic, lifestyle, and genetic factors, as well 
as availability of facilities for early diagnosis 
or treatment of cancers. Consequently, can-
cer survival can vary across individuals and 
populations (Kamangar et al., 2006b; Jemal 
et al., 2010; Slatore et al., 2010; Coleman 
et  al.,  2011).  However,  many  prognostic 
factors are not yet known. For example, 
low-cost  sequencing  may  enable  us  to Frontiers in Oncology  | Cancer Epidemiology and Prevention    April 2011  | Volume 1  | Article 3  |  4
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